MRNA

Placental errors may explain gestational diabetes risks, study finds

“By understanding how gestational diabetes disrupts the placenta at the molecular level, we can begin to imagine new ways to protect the offspring,” said Dr. Tal Schiller of HUJI Faculty of Medicine.

An opportunity arises to pause, breathe, and listen inward
 The researchers from Tel Aviv University (TAU) and the Israel Institute for Biological Research in the city of Nes Ziona.

Israeli researchers develop world-first mRNA vaccine against deadly bacteria

 The research team (Left to right) Prof. Dan Peer, Dr. Inbal Hazan-Halevy & Shani Benarroch.

Israeli researchers develop world's first mRNA-based vaccine against bacterium

 A 3D model of mRNA is displayed on the day of opening of German pharmaceuticals company BioNtech mRNA vaccine manufacturing plant to serve the African market in Kigali, Rwanda December 18, 2023.

Hebrew University study finds zebrafish provides clues to RNA's role in embryo formation


COVID-19 mRNA vaccines safe to use during pregnancy, study finds

Four percent more unvaccinated pregnant women had health complications than pregnant women who received the mRNA vaccine against COVID-19 after a week in a new study.

 Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm's China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.

Pfizer or Sinovac: Which COVID-19 vaccine booster is best? - study

A study on nearly 14 million people in Malaysia who were vaccinated with Pfizer, Sinovac or a combination of the two seems to indicate that Pfizer offers stronger protection.

Coronavirus vaccine under development (illustrative)

Israeli researchers develop AI machine-learning tool for cancer therapy

Their discovery is significant because it eliminates the need to compare the RNA from the tumor to DNA from healthy cells.

 Cancer Immunotherapy by  NIH Image Gallery.

Prior COVID offers less protection vs Omicron; mRNA booster shot efficacy declines within months

The immune response to COVID-19 helps protect against reinfection, but that protection is weaker against Omicron than it was against earlier variants of the coronavirus, according to new data.

 A NURSE prepares a dose of the COVID-19 vaccine as the new Omicron variant spreads, in Dutywa, in Eastern Cape province, South Africa this week.

In world first, S.Africa's Afrigen makes mRNA COVID vaccine using Moderna data

The vaccine candidate would be the first to be made based on a widely used vaccine without the assistance and approval of the developer.

 A production scientist works with samples during a visit by representatives of the Medicines Patent Pool, France and other European Union member states, at the Afrigen Biologics' site in Cape Town, South Africa, February 3, 2022.

Flu virus shells can assist mRNA delivery into cells - study

A recent UCSD study addresses the major issue of delivering biological drug molecules into cells safely and protecting them from endosomes.

 Virus microbiology cell (illustrative)

Experimental HIV vaccine based on mRNA safe for animals - study

The mRNA-based HIV vaccine is the same platform technology used in COVID-19 vaccines. 

 Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm's China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.

Moderna's mRNA-based flu vaccine shows promise in early-stage study

This data, though limited, puts Moderna ahead of other drugmakers, including rival Pfizer Inc, that are also testing their flu vaccine based on messenger RNA.

Moderna's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020.

Fetus brains unharmed by non-severe COVID-19

MRI scans showed "normal age-appropriate brain development" in a study of 33 pregnant women with mild or moderate COVID-19.

 A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021.

Could DNA vaccines be the next tool in the world’s battle against COVID-19?

India last month said that it had created the world’s first DNA vaccine, ZyCoV-D. While standard vaccines use actual 'hardware' protein, DNA vaccines use the 'software' blueprint of the virus.

 A man receives a dose of the COVISHIELD vaccine against the coronavirus disease (COVID-19), manufactured by Serum Institute of India, inside a passenger bus in Ahmedabad, India, September 23, 2021